3Qs: The future of Plan B

Todd Brown, vice chair of the Depart­ment of Phar­macy Prac­tice in the Bouvé Col­lege of Health Sci­ences, ana­lyzes the impact of pending changes to reg­u­la­tions gov­erning access to emer­gency contraceptives.

3Qs: Are cigarette warning labels effective?

This summer, the U.S. Food and Drug Admin­is­tra­tion unveiled graphic new cig­a­rette warning labels that will be required to appear on pack­ages starting next year. We talked to law pro­fessor Richard Day­nard, the pres­i­dent of the School of Law’s Public Health Advo­cacy Insti­tute and chair of its Tobacco Prod­ucts Lia­bility Project, about the effec­tive­ness of warning labels and a law­suit chal­lenging the new labels’ legality.

3Qs: From drug development to treating disease

Man­soor Amiji, dis­tin­guished pro­fessor and chair of phar­ma­ceu­tical sci­ences, tracks the drug dis­covery process, and ana­lyzes how the pur­suit of ‘block­buster’ drugs com­pares to treating patients with rare illnesses